<DOC>
	<DOC>NCT01733732</DOC>
	<brief_summary>The purpose of this study is to evaluate the ability of SYSTANE® BALANCE and SYSTANE® Gel to improve comfort in subjects with dry eyes.</brief_summary>
	<brief_title>SYSTANE® BALANCE Symptoms (OSDI) &amp; Inflammatory Biomarkers</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>Read, sign, and date the Informed Consent Document; Must not have used any topical ocular drops for approximately 24 hours prior to Visit 1; Meet the protocolspecified dry eye criteria at Screening Visit (Visit 1); Intraocular pressure (IOP) less than or equal to 22 millimeters of mercury (mmHg) in both eyes; Other protocoldefined inclusion criteria may apply. History or evidence of ocular or intraocular surgery or serious trauma in either eye within the past 6 months; Current punctal occlusion of any type (e.g., collagen plugs, silicone plugs); History or evidence of epithelial herpes simplex keratitis (dendritic keratitis); vaccinia; active or recent varicella viral disease of the cornea and/or conjunctiva; chronic bacterial disease of the cornea and/or conjunctiva and/or eyelids; mycobacterial infection of the eye; and/or fungal disease of the eye; Use of any concomitant topical ocular medications during the study period; Currently using Restasis but unwilling to discontinue its use 1 month prior to screening and for the entire study period; Use of systemic medications that may contribute to dry eye unless on a stable dosing regimen for a minimum of 30 days prior to Visit 1 and that remains stable throughout the study; Uncontrolled ocular conditions such as uveitis, glaucoma or any other ocular condition that may preclude the safe administration of either drop under investigation; Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Dry eye</keyword>
	<keyword>Lipid deficiency</keyword>
	<keyword>Inflammatory markers</keyword>
</DOC>